Geographical Location
stringclasses
54 values
Report Date
stringclasses
1 value
MDS Item Question/Description
stringclasses
828 values
MDS Item Response
stringclasses
303 values
Percent
stringlengths
1
5
Total Residents
stringlengths
1
7
Alabama
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Alabama
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
98.31
58
Alaska
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Alaska
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
*
*
Arizona
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Arizona
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
38
Arkansas
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
35
Arkansas
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
California
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
California
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
98.34
532
Colorado
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Colorado
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
23
Connecticut
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
98.63
72
Connecticut
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Delaware
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Delaware
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
90.48
19
District of Columbia
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
District of Columbia
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
*
*
Florida
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Florida
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
99.23
389
Georgia
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
99.02
101
Georgia
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Hawaii
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Hawaii
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
*
*
Idaho
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Idaho
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
*
*
Illinois
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Illinois
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
99.63
268
Indiana
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
105
Indiana
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Iowa
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Iowa
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
43
Kansas
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Kansas
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
43
Kentucky
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Kentucky
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
71
Louisiana
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Louisiana
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
97.7
85
Maine
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
*
*
Maine
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Maryland
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Maryland
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
118
Massachusetts
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Massachusetts
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
99.31
143
Michigan
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Michigan
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
127
Minnesota
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Minnesota
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
42
Mississippi
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Mississippi
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
98.48
65
Missouri
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Missouri
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
98.88
88
Montana
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Montana
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
*
*
Nebraska
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Nebraska
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
92
23
Nevada
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Nevada
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
20
New Hampshire
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
New Hampshire
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
93.75
15
New Jersey
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
New Jersey
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
98.97
289
New Mexico
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
New Mexico
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
16
New York
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
3.05
16
New York
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
96.95
508
North Carolina
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
North Carolina
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
97.27
107
North Dakota
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
North Dakota
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
*
*
Ohio
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Ohio
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
207
Oklahoma
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Oklahoma
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
98.15
53
Oregon
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
17
Oregon
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Pennsylvania
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Pennsylvania
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
97.93
189
Puerto Rico
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Puerto Rico
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
*
*
Rhode Island
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Rhode Island
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
85.71
12
South Carolina
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
98.31
58
South Carolina
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
South Dakota
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
South Dakota
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
11
Tennessee
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Tennessee
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
98.89
89
Texas
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Texas
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
98.7
228
Utah
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Utah
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
*
*
Vermont
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Vermont
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
*
*
Virgin Islands
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
*
*
Virgin Islands
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Virginia
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Virginia
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
100
98
Washington
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
Yes
*
*
Washington
Q1, 2025
A2122E: Identification Information - Route of Current Reconciled Medication List Transmission to Subsequent Provider: Other methods (e.g., texting, email, CDs)
No
95.92
47